arrow
Return

KIF2A characterization after spinal cord injury

delete2019-04-30
delete8
delete
OA
AI
O
Oscar Seira *
J
Jie Liu
P
Peggy Assinck
M
Matt S. Ramer
W
Wolfram Tetzlaff
DOI:10.1007/s00018-019-03116-2delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Axons in the central nervous system (CNS) typically fail to regenerate after injury. This failure is multi-factorial and caused in part by disruption of the axonal cytoskeleton. The cytoskeleton, in particular microtubules (MT), plays a critical role in axonal transport and axon growth during development. In this regard, members of the kinesin superfamily of proteins (KIFs) regulate the extension of primary axons toward their targets and control the growth of collateral branches. KIF2A negatively regulates axon growth through MT depolymerization. Using three different injury models to induce SCI in adult rats, we examined the temporal and cellular expression of KIF2A in the injured spinal cord. We observed a progressive increase of KIF2A expression with maximal levels at 10 days to 8 weeks post-injury as determined by Western blot analysis. KIF2A immunoreactivity was present in axons, spinal neurons and mature oligodendrocytes adjacent to the injury site. Results from the present study suggest that KIF2A at the injured axonal tips may contribute to neurite outgrowth inhibition after injury, and that its increased expression in inhibitory spinal neurons adjacent to the injury site might contribute to an intrinsic wiring-control mechanism associated with neuropathic pain. Further studies will determine whether KIF2A may be a potential target for the development of regeneration-promoting or pain-preventing therapies.
Keywords:
Kinesin
Cytoskeleton
Spinal cord injury
Regeneration
Neuropathic pain
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Cellular and Molecular Life Sciences cover
Cellular and Molecular Life Sciences
IF:
6.2
Papers:
9.1K
Citations:
4.0W

Organization

U
University of British Columbia
Scholars:
6.9W
Papers: 6.1W
Citations: 8.6W